The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index; 1 of the 24 sources its claims cite were checked for support.
ABO(H) Blood Group A and B Glycosyltransferases Recognize Substrate via Specific Conformational Changes
Open accessAbstract
The final step in the enzymatic synthesis of the ABO(H) blood group A and B antigens is catalyzed by two closely related glycosyltransferases, an alpha-(1-->3)-N-acetylgalactosaminyltransferase (GTA) and an alpha-(1-->3)-galactosyltransferase (GTB). Of their 354 amino acid residues, GTA and GTB differ by only four "critical" residues. High resolution structures for GTB and the GTA/GTB chimeric enzymes GTB/G176R and GTB/G176R/G235S bound to a panel of donor and acceptor analog substrates reveal "open," "semi-closed," and "closed" conformations as the enzymes go from the unliganded to the liganded states. In the open form the internal polypeptide loop (amino acid residues 177-195) adjacent to the active site in the unliganded or H antigen-bound enzymes is composed of two alpha-helices spanning Arg(180)-Met(186) and Arg(188)-Asp(194), respectively. The semi-closed and closed forms of the enzymes are generated by binding of UDP or of UDP and H antigen analogs, respectively, and show that these helices merge to form a single distorted helical structure with alternating alpha-3(10)-alpha character that partially occludes the active site. The closed form is distinguished from the semi-closed form by the ordering of the final nine C-terminal residues through the formation of hydrogen bonds to both UDP and H antigen analogs. The semi-closed forms for various mutants generally show significantly more disorder than the open forms, whereas the closed forms display little or no disorder depending strongly on the identity of residue 176. Finally, the use of synthetic analogs reveals how H antigen acceptor binding can be critical in stabilizing the closed conformation. These structures demonstrate a delicately balanced substrate recognition mechanism and give insight on critical aspects of donor and acceptor specificity, on the order of substrate binding, and on the requirements for catalysis.
Overview
CoChat Summary
TL;DR
The paper presents 12 crystal structures of ABO(H) blood group glycosyltransferases GTB (BBBB) and chimeras ABBB/AABB in open, semi-closed, and closed states, showing that substrate binding drives internal loop and C-terminal ordering. It concludes that UDP-donor binding precedes H antigen acceptor binding and that Arg/Gly176 controls loop flexibility and catalysis.
Key findings
- Three conformational states are observed: open in unliganded or H-antigen-bound enzymes, semi-closed with UDP, and closed with UDP or UDP-Gal plus acceptor. The internal loop (residues 176–195) moves up to 6 Å toward UDP, merging two α-helices into a distorted α-3₁₀-α helix, while the nine C-terminal residues order in the closed state.
- Arg176 versus Gly176 strongly affects order: structures containing Arg176 show significantly more order than Gly176 counterparts; unliganded BBBB has an almost entirely disordered internal loop, whereas unliganded ABBB is disordered only for Lys189, Ala177, and Arg176. BBBB+UDP+HA also displays higher thermal motion than ABBB+UDP+HA.
- ABBB and AABB bind UDP-Gal tightly with K_ib values of 1.6 and 1.1 µM, and acceptor K_ia values of 3.8 and 0.94 µM. The k_cat for UDP-Gal is comparable to GTB for ABBB but reduced from 5.1 to 2.2 s⁻¹ for AABB; UDP-GalNAc k_cat increases from 0.41 s⁻¹ for GTB to 0.65 and 0.60 s⁻¹ for ABBB and AABB. R188S and R188K dramatically reduce k_cat.
- The α-L-Fucp O-2 hydroxyl stabilizes the C-terminus: ABBB+UDP+HA orders all nine C-terminal residues, whereas substituting ADA lacking O-2 causes disorder of His348 and Arg352 side chains. AABB+UDP-Gal+DA forms the closed state with UDP-Gal and DA, and Ser185 provides a steric barrier to UDP-Glc binding.
Methods
- Synthetic chimeric genes ABBB and AABB and site-directed mutants R188S, R188K, and R188H were expressed in *E. coli* and purified; final yields were ABBB 36 mg/L, AABB 50 mg/L, R188S 8 mg/L, R188K 66 mg/L, and R188H 15 mg/L.
- Kinetics used a radiochemical assay with Sep-Pak reverse-phase cartridges at 37 °C in 50 mM MOPS, pH 7.0, 20 mM MnCl₂, and 1 mg/ml BSA; seven donor and acceptor concentrations were used, with Michaelis-Menten nonlinear regression and two-substrate analysis for AABB and ABBB.
- Crystallography determined 12 structures of BBBB, ABBB, and AABB soaked with combinations of UDP, UDP-Gal, H antigen disaccharide (HA), 3-deoxy acceptor (DA), and 2-deoxy-Fuc-3-amino-Gal acceptor (ADA); diffraction data were collected at −160 °C, structures solved by molecular replacement using wild-type GTB (PDB 1LZ7), and refined with REFMAC5. Resolutions ranged from 1.75 to 1.41 Å, with R_work 19.4–22.3% and R_free 21.7–24.6%.
Limitations
- Stated in the paper: attempts to crystallize ABBB with UDP-Gal gave only low UDP occupancy and no conformational shift, suggesting the Gal moiety was disordered or UDP-Gal had hydrolyzed, so that structure was not included. Some structures had partial UDP occupancy, BBBB+UDP+HA lacked electron density for the last three C-terminal residues, and R188H had only 3% of the specific activity of R188K and was not further characterized.
- Stated in the paper: in AABB+UDP-Gal+DA, the acceptor Gal-O-3 is modeled and does not appear in the 3-deoxy acceptor DA.
- Evident from the text: conclusions about the catalytic cycle and substrate-binding order rely on static crystal structures plus kinetics, with no direct time-resolved dynamics; several mutant/ligand combinations were not structurally characterized, and disorder or partial occupancy limits atomic detail in the mobile loops.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
1 Valid · 0 Not valid · 17 Not checked · 100 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“whereas Gly/Ser 235 and Leu/Met 266 significantly impact acceptor recognition (33)”
§ ABO(H) Blood Group A and B Glycosyltransferases Recognize Substrate via Specific Conformational Changes * > Abstract
What the sources say
- Supportedcites [33] Letts, 2006, J. Biol. Chem. source
The Abstract (p. 1) states directly that 'acceptor binding and subsequent transfer are significantly influenced by two of these residues: Gly/Ser-235 and Leu/Met-266.' The Discussion ('Two Critical Residues Dramatically Alter the Stability of the Acceptor Recognition Site') and the Conclusions corroborate that these two residues have a significant differential impact on acceptor binding, with detailed structural evidence for both residues across the Gal, Lac/LacNAc and HI/HII complexes. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Binding of both substrates in the BBBBϩUDPϩHA complex causes most of the polypeptide main chain of the internal and C-terminal loops to become ordered and so form the closed state.”
§ ABO(H) Blood Group A and B Glycosyltransferases Recognize Substrate via Specific Conformational Changes * > Polypeptide Movement in GTA and GTB
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The fully liganded ABBB enzyme shows ordering of almost all previously disordered residues in both the C terminus and internal loop.”
§ ABO(H) Blood Group A and B Glycosyltransferases Recognize Substrate via Specific Conformational Changes * > UDP Binding Induces a Semi-closed Conformation-The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The shift to the closed conformation does bring Ser 185 and Arg 188 into the donor sugar binding site”
§ ABO(H) Blood Group A and B Glycosyltransferases Recognize Substrate via Specific Conformational Changes * > UDP Binding Induces a Semi-closed Conformation-The
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The semiclosed and closed forms of the enzymes are generated by binding of UDP or of UDP and H antigen analogs, respectively”
§ ABO(H) Blood Group A and B Glycosyltransferases Recognize Substrate via Specific Conformational Changes * > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
57 more claims
Create a free account to see all 118 claims and to verify the 21 references still open.
- It may state two separate claims as one. 49
- The quote only partly states this claim. 2
- Probably not a substantial claim. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, the AAGlyB-3 structure shows the GalNAc ring in a conformation clearly different from the canonical tucked under conformation we have seen in previous blood group enzyme structures with UDP-Gal, 1, or 2 and which is the conformation generally adopted by both UDP-Gal and UDP-GalNAc at a GT binding site (Fig. 3) (7, 12, 15–18, 20, 22–24).”
From Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase (2015) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In this new structure, the GalNAc moiety is placed in the active site in a conformation, which is different from the canonical tucked under conformation previously observed in other UDP-sugar-GT complex structures (7, 12, 15–18, 20–24).”
From Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase (2015) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“Further, ABBA in complex with UDP-Glc shows that residues Met-186 and Ser-185 are offset significantly compared with their position in the ordered Alfaro et al. (12) AABBϩUDP-Gal structure.”
The cited source says what the claim attributes to it.
In the citing paper
“GTA and ABBA adopt the closed state with structured internal and C-terminal loops (Table 4) when in complex with UDP-Gal and DI, similar to the previously published AABB structure (12).”
In the citing paper
“Structures of AAGlyB in complex with 1 and 2 show that the donor derivatives are binding in the active site with the galactose in the “tucked under” conformation as seen previously with native UDP-Gal (15–18).”
From Novel UDP-GalNAc Derivative Structures Provide Insight into the Donor Specificity of Human Blood Group Glycosyltransferase (2015) · cites this paper as [15]
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ ABO(H) Blood Group A and B Glycosyltransferases Recognize Substrate via Specific Conformational Changes * > UDP Binding Induces a Semi-closed Conformation-The
“the internal loop in the unliganded BBBB structure is almost entirely disordered”
§ ABO(H) Blood Group A and B Glycosyltransferases Recognize Substrate via Specific Conformational Changes * > Polypeptide Movement in GTA and GTB
“There are only 4 residues (Ala 177 to Arg 180 ) disordered in the internal loop of BBBB”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ ABO(H) Blood Group A and B Glycosyltransferases Recognize Substrate via Specific Conformational Changes * > Polypeptide Movement in GTA and GTB
“The most striking structures in this series are ABBBϩUDPϩHA and AABBϩUDP-GalϩDA, which both display excellent electron density for almost the entire polypeptide chain (including the C-terminal residues) and unambiguous electron density for both the UDP and the HA.”
§ ABO(H) Blood Group A and B Glycosyltransferases Recognize Substrate via Specific Conformational Changes * > Polypeptide Movement in GTA and GTB
“The structure of AABBϩUDP-GalϩDA displays electron density corresponding to UDP-Gal and a fully occupied DA.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ ABO(H) Blood Group A and B Glycosyltransferases Recognize Substrate via Specific Conformational Changes * > Abstract
“GTB/G176R/ G235S”
§ ABO(H) Blood Group A and B Glycosyltransferases Recognize Substrate via Specific Conformational Changes * > Abstract
“AABB would correspond to the GTB/G176R/S235G mutant enzyme”
Citations
Cites
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
SETOR: Hardware-lighted three-dimensional solid model representations of macromolecules
Evans, S. V. (1993) · Journal of Molecular Graphics · doi:10.1016/0263-7855(93)87009-t · Cited by 1,279
Self-citationThe finer things in X-ray diffraction data collection
Pflugrath, J. W. (1999) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s090744499900935x · Cited by 1,244
Molecular genetic basis of the histo-blood group ABO system
Yamamoto, F.-I., Clausen, H., White, T., Marken, J., & Hakomori, S.-I. (1990) · Nature · doi:10.1038/345229a0 · Cited by 1,181
Structures and mechanisms of glycosyltransferases
Breton, C., Šnajdrová, L., Jeanneau, C., Koča, J., & Imberty, A. (2006) · Glycobiology · doi:10.1093/glycob/cwj016 · Cited by 711
An approach to multi-copy search in molecular replacement
Vagin, A., & Teplyakov, A. (2000) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444900013780 · Cited by 706
Glycoside hydrolases and glycosyltransferases: families and functional modules
Bourne, Y., & Henrissat, B. (2001) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00253-0 · Cited by 445
Kabat, E. A. (1956) · Cited by 347
Charnock, S. J., & Davies, G. J. (1999) · Biochemistry · doi:10.1021/bi990270y · Cited by 345
Recent structural insights into the expanding world of carbohydrate-active enzymes
Davies, G. J., Gloster, T. M., & Henrissat, B. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.10.008 · Cited by 314
Cited by
Enzymes in the Synthesis of Glycoconjugates
Schmaltz, R. M., Hanson, S. R., & Wong, C.-H. (2011) · Chemical Reviews · doi:10.1021/cr200113w · Cited by 283
Emerging structural insights into glycosyltransferase-mediated synthesis of glycans
Moremen, K. W., & Haltiwanger, R. S. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0350-2 · Cited by 209
The conformational plasticity of glycosyltransferases
Albesa-Jové, D., & Guerin, M. E. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.07.007 · Cited by 107
Trapping and characterization of covalent intermediates of mutant retaining glycosyltransferases
Soya, N., Fang, Y. R., Palcic, M. M., & Klassen, J. S. (2010) · Glycobiology · doi:10.1093/glycob/cwq190 · Cited by 97
Self-citationYang, T., Zhang, J., Ke, D., Yang, W., Tang, M., Jiang, J. D., Cheng, G., Li, J., Cheng, W., Wei, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11154-4 · Cited by 94
Crossroads between Bacterial and Mammalian Glycosyltransferases
Brockhausen, I. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00492 · Cited by 84
Structural and mechanistic basis for a new mode of glycosyltransferase inhibition
Pesnot, T., Jørgensen, R., Palcic, M. M., & Wagner, G. K. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.343 · Cited by 75
Self-citationSobhanifar, S., Worrall, L. J., King, D. T., Wasney, G. A., Baumann, L., Gale, R. T., Nosella, M. L., Brown, E. D., Withers, S. G., & Strynadka, N. C. J. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1006067 · Cited by 72
Albesa-Jové, D., Mendoza, F., Rodrigo‐Unzueta, A., Gomollón‐Bel, F., Cifuente, J. O., Urresti, S., Comino, N., Gómez, H., Romero‐García, J., Lluch, J. M., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201504617 · Cited by 49
Shoemaker, G. K., Soya, N., Palcic, M. M., & Klassen, J. S. (2008) · Glycobiology · doi:10.1093/glycob/cwn043 · Cited by 48
Self-citationChemoenzymatic Synthesis of Unnatural Nucleotide Sugars for Enzymatic Bioorthogonal Labeling
Wen, L., Gadi, M. R., Zheng, Y., Gibbons, C., Kondengaden, S. M., Zhang, J., & Wang, P. G. (2018) · ACS Catalysis · doi:10.1021/acscatal.8b02081 · Cited by 46
Geometric Attributes of Retaining Glycosyltransferase Enzymes Favor an Orthogonal Mechanism
Schuman, B., Evans, S. V., & Fyles, T. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071077 · Cited by 43
Self-citationDesign of Glycosyltransferase Inhibitors: Pyridine as a Pyrophosphate Surrogate
Wang, S., Cuesta-Seijo, J. A., Lafont, D., Palcic, M. M., & Vidal, S. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201301871 · Cited by 42
Self-citationInhibition of galactosyltransferases by a novel class of donor analogues
Descroix, K., Pesnot, T., Yoshimura, Y., Gehrke, S. S., Wakarchuk, W., Palcic, M. M., & Wagner, G. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201154p · Cited by 36
Self-citationSoya, N., Shoemaker, G. K., Palcic, M. M., & Klassen, J. S. (2009) · Glycobiology · doi:10.1093/glycob/cwp114 · Cited by 35
Self-citationDominant versus recessive: Molecular mechanisms in metabolic disease
Zschocke, J. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-1016-5 · Cited by 33
Sindhuwinata, N., Munoz, E., Munoz, F. J., Palcic, M. M., Peters, H., & Peters, T. (2010) · Glycobiology · doi:10.1093/glycob/cwq019 · Cited by 33
Self-citationMechanistic Insights into the Retaining Glucosyl-3-phosphoglycerate Synthase from Mycobacteria
Urresti, S., Albesa-Jové, D., Schaeffer, F., Pham, H. T. T., Kaur, D., Gest, P. M., van der Woerd, M. J., Carreras‐González, A., López‐Fernández, S., Alzari, P. M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.368191 · Cited by 29
Schaefer, K., Albers, J., Sindhuwinata, N., Peters, T., & Meyer, B. (2012) · ChemBioChem · doi:10.1002/cbic.201100642 · Cited by 27
Sakono, M., Seko, A., Takeda, Y., Hachisu, M., & Ito, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.112 · Cited by 26
Brew, K., Tumbale, P. P., & Acharya, K. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.176248 · Cited by 26
Turning universal O into rare Bombay type blood
Anso, I., Naegeli, A., Cifuente, J. O., Orrantia, A., Andersson, E., Zenarruzabeitia, O., Moraleda-Montoya, A., García-Alija, M., Corzana, F., Orbe, R. D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37324-z · Cited by 25
Jørgensen, R., Grimm, L. L., Sindhuwinata, N., Peters, T., & Palcic, M. M. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201108345 · Cited by 24
Self-citationBobovská, A., Tvaroška, I., & Kóňa, J. (2014) · Glycobiology · doi:10.1093/glycob/cwu085 · Cited by 24
Structural Snapshots and Loop Dynamics along the Catalytic Cycle of Glycosyltransferase GpgS
Albesa-Jové, D., Romero‐García, J., Sancho‐Vaello, E., Contreras, F. ‐., Rodrigo‐Unzueta, A., Comino, N., Carreras‐González, A., Arrasate, P., Urresti, S., Biarnés, X., et al. (2017) · Structure · doi:10.1016/j.str.2017.05.009 · Cited by 22
Tumbale, P., Jamaluddin, H., Thiyagarajan, N., Brew, K., & Acharya, K. R. (2008) · Biochemistry · doi:10.1021/bi800852a · Cited by 17
Rademacher, C., Landström, J., Sindhuwinata, N., Palcic, M. M., Widmalm, G., & Peters, T. (2010) · Glycoconjugate Journal · doi:10.1007/s10719-010-9282-5 · Cited by 17
Self-citationThiyagarajan, N., Pham, T. T. K., Stinson, B., Sundriyal, A., Tumbale, P., Lizotte-Waniewski, M., Brew, K., & Acharya, K. R. (2012) · Scientific Reports · doi:10.1038/srep00940 · Cited by 19
A Novel Fluorescent Probe for Retaining Galactosyltransferases
Pesnot, T., Palcic, M. M., & Wagner, G. K. (2010) · ChemBioChem · doi:10.1002/cbic.201000013 · Cited by 20
Self-citationBiosynthesis of Complex Mucin-Type O-Glycans
Brockhausen, I. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00643-2 · Cited by 20
Pasek, M., Ramakrishnan, B., Boeggeman, E. E., Manzoni, M., Waybright, T. J., & Qasba, P. K. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800534r · Cited by 20
Base-modified donor analogues reveal novel dynamic features of a glycosyltransferase
Jørgensen, R., Pesnot, T., Lee, H. J., Palcic, M. M., & Wagner, G. K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.465963 · Cited by 19
Self-citationPham, T. T. K., Stinson, B., Thiyagarajan, N., Lizotte-Waniewski, M., Brew, K., & Acharya, K. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.545384 · Cited by 19
Gagnon, S. M. L., Meloncelli, P. J., Zheng, R. B., Haji-Ghassemi, O., Johal, A. R., Borisova, S. N., Lowary, T. L., & Evans, S. V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.682401 · Cited by 17
Self-citationAssociation between ABO blood types and pain perception
Simoni, A. H., Jerwiarz, A., Randers, A., & Gazerani, P. (2017) · Somatosensory & Motor Research · doi:10.1080/08990220.2018.1425675 · Cited by 17
Unraveling structural insights of ribokinase from Leishmania donovani
Gatreddi, S., Pillalamarri, V., Vasudevan, D., Addlagatta, A., & Qureshi, I. A. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.06.001 · Cited by 16
Xu, F., Yin, J., Xiong, E., He, H., Zhang, Q., Fan, S., Qin, X., & Wang, S. (2019) · Disease Markers · doi:10.1155/2019/1761693 · Cited by 16
Kooy, F. K., Beeftink, H. H., Eppink, M. H. M., TRAMPER, J., Eggink, G., & Boeriu, C. G. (2014) · Journal of Molecular Catalysis B Enzymatic · doi:10.1016/j.molcatb.2014.02.006 · Cited by 15
Schaefer, K., Sindhuwinata, N., Hackl, T., Kötzler, M. P., Niemeyer, F. C., Palcic, M. M., Peters, T., & Meyer, B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm300642a · Cited by 15
Self-citationSchuman, B., Persson, M., Landry, R. C., Polakowski, R., Weadge, J. T., Seto, N. O. L., Borisova, S. N., Palcic, M. M., & Evans, S. V. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.07.036 · Cited by 11
Self-citationBlackler, R. J., Gagnon, S. M. L., Polakowski, R., Rose, N. L., Zheng, R. B., Letts, J. A., Johal, A. R., Schuman, B., Borisova, S. N., Palcic, M. M., et al. (2016) · Glycobiology · doi:10.1093/glycob/cww117 · Cited by 14
Self-citationYamamoto, M., Cid, E., & Yamamoto, F. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017009795 · Cited by 13
Cid, E., Yamamoto, M., & Yamamoto, F. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018017293 · Cited by 13
Sindhuwinata, N., Grimm, L. L., Weißbach, S., Zinn, S., Muñoz, E. M., Palcic, M. M., & Peters, T. (2013) · Biopolymers · doi:10.1002/bip.22297 · Cited by 13
Self-citationWagner, G. K., Pesnot, T., Palcic, M. M., & Jørgensen, R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.681262 · Cited by 12
Self-citationGagnon, S. M. L., Legg, M. S. G., Polakowski, R., Letts, J. A., Persson, M., Lin, S., Zheng, R. B., Rempel, B., Schuman, B., Haji-Ghassemi, O., et al. (2018) · Glycobiology · doi:10.1093/glycob/cwy051 · Cited by 12
Self-citationJohal, A. R., Schuman, B., Alfaro, J. A., Borisova, S., Seto, N. O. L., & Evans, S. V. (2012) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444912001801 · Cited by 10
Self-citationZeng, J., Ma, M., Jiang, X., Rao, Z., Huang, D. Y., Zhang, H., Yin, S., Bao, R., Zhang, H., Wang, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56563-w · Cited by 11
Flügge, F., & Peters, T. (2018) · Journal of Biomolecular NMR · doi:10.1007/s10858-018-0183-4 · Cited by 11
Cid, E., Yamamoto, M., & Yamamoto, F. (2019) · Scientific Reports · doi:10.1038/s41598-018-37515-5 · Cited by 11
Albesa-Jové, D., Cifuente, J. O., Trastoy, B., & Guerin, M. E. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.02.034 · Cited by 11
Design of Glycosyltransferase Inhibitors: Serine Analogues as Pyrophosphate Surrogates?
Wang, S., Cuesta-Seijo, J. A., Striebeck, A., Lafont, D., Palcic, M. M., & Vidal, S. (2015) · ChemPlusChem · doi:10.1002/cplu.201500282 · Cited by 11
Self-citationBiomimetic Principles to Develop Blood Compatible Surfaces
Semak, V., Fischer, M. B., & Weber, V. (2017) · The International Journal of Artificial Organs · doi:10.5301/ijao.5000559 · Cited by 11
Johal, A. R., Blackler, R. J., Alfaro, J. A., Schuman, B., Borisova, S., & Evans, S. V. (2014) · Glycobiology · doi:10.1093/glycob/cwt098 · Cited by 5
Self-citationGlycosyltransferase 8 domain-containing protein 1 (GLT8D1) is a UDP-dependent galactosyltransferase
Vicente, J. B., Guerreiro, A. C. L., Felgueiras, B., Chapla, D. G., Tehrani, D., Moremen, K. W., & Costa, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-48605-4 · Cited by 9
Nucleoside Diphosphate Sugar Analogues that Target Glycosyltransferases
Merino, P., Delso, I., Tejero, T., Ghirardello, M., & Juste‐Navarro, V. (2016) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.201600396 · Cited by 9
Gagnon, S. M. L., Legg, M. S. G., Sindhuwinata, N., Letts, J. A., Johal, A. R., Schuman, B., Borisova, S. N., Palcic, M. M., Peters, T., & Evans, S. V. (2017) · Glycobiology · doi:10.1093/glycob/cwx053 · Cited by 9
Self-citationAssociation Between the ABO Blood Types and Post-operative Pain
Lausten, M. B., Rasmussen, S., & Gazerani, P. (2018) · European Neurological Review · doi:10.17925/enr.2018.13.1.38 · Cited by 8
Zouine, S., MARNISSI, F., Otmani, N., Othmani, M. B., Zaïd, N., Kojok, K., Zaid, Y., Jouti, N. T., & Habti, N. (2020) · Journal of Breast Cancer · doi:10.4048/jbc.2020.23.e13 · Cited by 8
Wang, Z., Jin, S., Zheng, J., Qian, C., Caib, X., & Xiang, D. (2024) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2024.04.127 · Cited by 7
Jørgensen, R., Grimm, L. L., Sindhuwinata, N., Peters, T., & Palcic, M. M. (2012) · Angewandte Chemie · doi:10.1002/ange.201108345 · Cited by 7
Self-citationYamamoto, F., Yamamoto, M., & Blancher, A. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02463.x · Cited by 7
Enzymatic production of hyaluronan oligo- and polysaccharides
Kooy, F. K. (2010) · doi:10.18174/138789 · Cited by 7
Protein NMR Studies of Substrate Binding to Human Blood Group A and B Glycosyltransferases
Grimm, L. L., Weißbach, S., Flügge, F., Begemann, N., Palcic, M. M., & Peters, T. (2017) · ChemBioChem · doi:10.1002/cbic.201700025 · Cited by 6
Self-citationp.R180C mutation of glycosyltransferase B leads to B subgroup, an in vitro and in silico study
Cai, X., Li, F., Lei, H., Qu, S. J., Qian, C., Xiang, D., Wei, D., Wu, W., Xu, Q., & Wang, X. (2018) · Vox Sanguinis · doi:10.1111/vox.12655 · Cited by 6
ABO, H, LE, P1PK, GLOB, I and FORS Blood Group Systems
Klein, H. G., & Anstee, F. D. J. (2013) · Wiley eBooks · doi:10.1002/9781118689943.ch4 · Cited by 6
Glycan synthesis with SpyCatcher-SpyTag immobilized Leloir-glycosyltransferases
Palm, P., Hussnaetter, K. P., & Elling, L. (2025) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-025-13602-2 · Cited by 5
Fragment Growing to Design Optimized Inhibitors for Human Blood Group B Galactosyltransferase (GTB)
Strecker, C., Peters, H., Hackl, T., Peters, T., & Meyer, B. (2019) · ChemMedChem · doi:10.1002/cmdc.201900296 · Cited by 5
Protein O-Fucosyltransferase 1 Undergoes Interdomain Flexibility in Solution
Lira‐Navarrete, E., Pallarés, M. C., Castello, F., Ruedas-Rama, M. J., Orte, Á., Lostao, A., & Hurtado‐Guerrero, R. (2021) · Molecules · doi:10.3390/molecules26082105 · Cited by 5
Albesa-Jové, D., Mendoza, F., Rodrigo‐Unzueta, A., Gomollón‐Bel, F., Cifuente, J. O., Urresti, S., Comino, N., Gómez, H., Romero‐García, J., Lluch, J. M., et al. (2015) · Angewandte Chemie · doi:10.1002/ange.201504617 · Cited by 5
Schuman, B., Fisher, S. Z., Kovalevsky, A. Y., Borisova, S. N., Palcic, M. M., Coates, L., Langan, P. A., & Evans, S. V. (2011) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309110051298 · Cited by 5
Self-citationWeißbach, S., Flügge, F., & Peters, T. (2018) · ChemBioChem · doi:10.1002/cbic.201800019 · Cited by 4
Niwa, R., Nakayama, T., Ishii, H., Fujita, E., Ishiyama, K., Matsuo, T., Shimizu, A., Gao, S., Hayashi, M., Katai, A., et al. (2016) · Transfusion · doi:10.1111/trf.13507 · Cited by 4
He, Y., Lu, Y., Zhang, J., He, Y., Niu, D., & Deng, G. (2024) · Transfusion · doi:10.1111/trf.18039 · Cited by 3
Jørgensen, R., Batot, G., Mannerstedt, K., Imberty, A., Breton, C., Hindsgaul, O., Royant, A., & Palcic, M. M. (2014) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x1401259x · Cited by 3
Self-citationSynthetically Useful Glycosyltransferases for the Access of Mammalian Glycomes
Guan, W., Edmunds, G. A., Wu, Z., & Li, L. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016575-00046 · Cited by 3
Insights into Allosteric Control of Human Blood Group A and B Glycosyltransferases from Dynamic NMR
Flügge, F., & Peters, T. (2019) · ChemistryOpen · doi:10.1002/open.201900116 · Cited by 3
ABO blood group distribution in patients with upper urinary tract stones: a case–control study
Durmuş, E., Sevim, M., & Ok, F. (2026) · Urolithiasis · doi:10.1007/s00240-026-01998-z · Cited by 1
Flexibility and mutagenic resiliency of glycosyltransferases
Bay, M. L., Cuesta-Seijo, J. A., Weadge, J. T., Persson, M., & Palcic, M. M. (2014) · Glycoconjugate Journal · doi:10.1007/s10719-014-9542-x · Cited by 1
Self-citationNMR Analysis of Glycosyltransferases
Peters, T. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782623946-00179 · Cited by 1
A STUDY ON PAIN PERCEPTION INDUCED BY COLD PRESSOR TEST AMONG DIFFERENT ABO BLOOD GROUPS
Rajkumari, R., Keithellakpam, S., Thiyam, J., Srivastava, A., & Minita Devi, N. (2019) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2019/511 · Cited by 1
Theoretical Study of the Catalytic Mechanism of Retaining Glycosyltransferases
Gómez, H., & de Química, U. A. D. B. D. (2013) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya) · Cited by 1
Une nouvelle approche pour étudier le mécanisme des glycosyltransférases
Batot, G. (2013) · theses.fr (ABES) · doi:10.70675/60c190ddz8257z43b4z951bzadd43ca1200f · Cited by 1
MacMaster, J. S. (2015) · DukeSpace (Duke University) · Cited by 1
Alagesan, K. (2017) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-5305
Identification, Characterization, and Utilization of Glycosyltransferases
Pettit, N. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
Advancing mechanistic understanding of glycosyltransferases
Gagnon, S. M. L. (2019) · UVic’s Research and Learning Repository (University of Victoria)
Леонидовна, П. Н., Георгиевна, Н. Е., Ilyenkova, N. A., & Grishkevich, N. Y. (2020) · Вопросы современной педиатрии · doi:10.15690/vsp.v19i1.2083
Gagnon, S. M. L., Meloncelli, P. J., Zheng, R. B., Haji‐Ghassemi, O., Johal, A. R., Borisova, S. N., Lowary, T. L., & Evans, S. V. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.a115.682401
Self-citationHisto-Blood Group A and B Transferases, Their Gene Structures, and Common O Group Gene Structures
Hakomori, S.-I., & Palcic, M. M. (2014) · Springer eBooks · doi:10.1007/978-4-431-54240-7_158
Self-citationHisto-Blood Group A Variants, O Variants, and Their Alleles
Hakomori, S., & Palcic, M. M. (2014) · Springer eBooks · doi:10.1007/978-4-431-54240-7_159
Self-citationAzeem, M., Lee, C., Hein, A., Ott, C., & Valafar, H. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1694750
Synthesis and biological evaluation of neutral glycosyltransferase inhibitors
Wang, S. (2013) · theses.fr (ABES) · doi:10.70675/b55201c3z9af6z4978z9ac8z09fb8db2f9c2
Xu, X., Cai, K., Liang, P., Zhu, L., Liu, Q., & Li, Y. (2026) · Transfusion · doi:10.1111/trf.70312
BindingDB Entry 50040142: Inhibition of galactosyltransferases by a novel class of donor analogues.
BindingDB (2013) · UC San Diego · doi:10.7270/q28w3fch
Deveci, G., Kızılyıldırım, S., Aydın, E., Alsubarı, N. M. H. A., Arslan, Ş., türkmen, N. B., Yaşar, Ş., Donma, M. M., Arıkan, Y., DEMİR, M. B., et al. (2026) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.4366
Metadata
- Authors
- Alfaro, J. A., Zheng, R. B., Persson, M., Letts, J. A., Polakowski, R., Bai, Y., Borisova, S. N., Seto, N. O. L., Lowary, T. L., Palcic, M. M., & Evans, S. V.
- Affiliations
- University of Victoria (CA)
- University of Alberta (CA)
- Carlsberg Laboratory (DK)
- Corresponding author
- Evans, Stephen V.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 283
- Issue
- 15
- Pages
- 10097-10108
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1980671235
- Cited by
- 96
- References
- 56
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 2 · 2023: 2 · 2021: 1 · 2020: 2 · 2019: 11 · 2018: 7 · 2017: 8 · 2016: 6 · 2015: 6 · 2014: 8 · 2013: 10 · 2012: 8
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4562 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Keywords
- ABO blood group antigens, glycosyltransferases, alpha-1,3-galactosyltransferase, substrate recognition, conformational change, H antigen, chimeric enzymes, active site occlusion, acceptor specificity
- MeSH terms
- ABO Blood-Group System, Catalysis, Galactosyltransferases, Humans, Hydrogen Bonding, Recombinant Fusion Proteins, Substrate Specificity, Uridine Diphosphate, N-Acetylgalactosaminyltransferases, Protein Structure, Secondary, Protein Structure, Tertiary, Amino Acid Substitution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.